vs
Side-by-side financial comparison of Inspirato Inc (ISPO) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $55.5M, roughly 1.4× Inspirato Inc). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -19.6%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-3.0M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -11.4%).
Inspirato Inc is a luxury travel and hospitality subscription service provider catering primarily to high-net-worth consumers across North America. It offers curated premium villa rentals, exclusive resort access, customized trip planning, and corporate travel incentive solutions for enterprise clients.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
ISPO vs PBYI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.5M | $75.5M |
| Net Profit | $-4.5M | — |
| Gross Margin | 31.4% | 69.3% |
| Operating Margin | -8.0% | 22.7% |
| Net Margin | -8.1% | — |
| Revenue YoY | -19.6% | 27.7% |
| Net Profit YoY | -204.4% | — |
| EPS (diluted) | $-0.36 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $75.5M | ||
| Q3 25 | $55.5M | $54.5M | ||
| Q2 25 | $63.1M | $52.4M | ||
| Q1 25 | $65.9M | $46.0M | ||
| Q4 24 | $63.1M | $59.1M | ||
| Q3 24 | $69.1M | $80.5M | ||
| Q2 24 | $67.4M | $47.1M | ||
| Q1 24 | $80.2M | $43.8M |
| Q4 25 | — | — | ||
| Q3 25 | $-4.5M | $8.8M | ||
| Q2 25 | $-5.3M | $5.9M | ||
| Q1 25 | $1.6M | $3.0M | ||
| Q4 24 | $-2.3M | — | ||
| Q3 24 | $4.3M | $20.3M | ||
| Q2 24 | $-8.7M | $-4.5M | ||
| Q1 24 | $1.3M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | 31.4% | 77.7% | ||
| Q2 25 | 27.5% | 76.5% | ||
| Q1 25 | 38.8% | 77.1% | ||
| Q4 24 | 34.7% | 76.4% | ||
| Q3 24 | 71.5% | 63.9% | ||
| Q2 24 | 24.0% | 77.4% | ||
| Q1 24 | 39.5% | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | -8.0% | 17.6% | ||
| Q2 25 | -8.3% | 12.7% | ||
| Q1 25 | 2.5% | 8.7% | ||
| Q4 24 | -3.2% | 22.6% | ||
| Q3 24 | 9.8% | 27.4% | ||
| Q2 24 | -22.8% | -4.6% | ||
| Q1 24 | 3.0% | -5.3% |
| Q4 25 | — | — | ||
| Q3 25 | -8.1% | 16.2% | ||
| Q2 25 | -8.4% | 11.2% | ||
| Q1 25 | 2.5% | 6.5% | ||
| Q4 24 | -3.6% | — | ||
| Q3 24 | 6.3% | 25.2% | ||
| Q2 24 | -12.9% | -9.6% | ||
| Q1 24 | 1.6% | -11.0% |
| Q4 25 | — | $0.26 | ||
| Q3 25 | $-0.36 | $0.17 | ||
| Q2 25 | $-0.42 | $0.12 | ||
| Q1 25 | $0.12 | $0.06 | ||
| Q4 24 | $0.98 | $0.40 | ||
| Q3 24 | $0.62 | $0.41 | ||
| Q2 24 | $-2.33 | $-0.09 | ||
| Q1 24 | $-0.18 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.7M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $-134.0M | $130.3M |
| Total Assets | $228.3M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | $13.7M | $94.4M | ||
| Q2 25 | $16.7M | $96.0M | ||
| Q1 25 | $16.4M | $93.2M | ||
| Q4 24 | $21.8M | $101.0M | ||
| Q3 24 | $13.5M | $96.7M | ||
| Q2 24 | $18.8M | $96.8M | ||
| Q1 24 | $22.6M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | — | $130.3M | ||
| Q3 25 | $-134.0M | $115.3M | ||
| Q2 25 | $-129.7M | $104.7M | ||
| Q1 25 | $-125.2M | $97.1M | ||
| Q4 24 | $-129.9M | $92.1M | ||
| Q3 24 | $-134.6M | $71.1M | ||
| Q2 24 | $-35.2M | $48.5M | ||
| Q1 24 | $-27.5M | $51.0M |
| Q4 25 | — | $216.3M | ||
| Q3 25 | $228.3M | $202.9M | ||
| Q2 25 | $252.6M | $194.9M | ||
| Q1 25 | $270.1M | $196.2M | ||
| Q4 24 | $273.9M | $213.3M | ||
| Q3 24 | $273.3M | $220.7M | ||
| Q2 24 | $301.7M | $205.0M | ||
| Q1 24 | $313.0M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.2M | $14.4M |
| Free Cash FlowOCF − Capex | $-3.0M | $14.4M |
| FCF MarginFCF / Revenue | -5.4% | 19.1% |
| Capex IntensityCapex / Revenue | 1.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-31.2M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $14.4M | ||
| Q3 25 | $-2.2M | $9.7M | ||
| Q2 25 | $1.1M | $14.1M | ||
| Q1 25 | $-6.6M | $3.6M | ||
| Q4 24 | $-15.8M | $15.6M | ||
| Q3 24 | $-13.7M | $11.0M | ||
| Q2 24 | $-1.8M | $1.0M | ||
| Q1 24 | $-7.2M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | $-3.0M | $9.7M | ||
| Q2 25 | $468.0K | $14.1M | ||
| Q1 25 | $-7.5M | $3.6M | ||
| Q4 24 | $-21.2M | $15.6M | ||
| Q3 24 | $-14.8M | $11.0M | ||
| Q2 24 | $-3.7M | $1.0M | ||
| Q1 24 | $-8.5M | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | -5.4% | 17.7% | ||
| Q2 25 | 0.7% | 26.8% | ||
| Q1 25 | -11.4% | 7.7% | ||
| Q4 24 | -33.7% | 26.4% | ||
| Q3 24 | -21.5% | 13.7% | ||
| Q2 24 | -5.5% | 2.1% | ||
| Q1 24 | -10.6% | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | 1.4% | 0.0% | ||
| Q2 25 | 1.0% | 0.0% | ||
| Q1 25 | 1.3% | 0.1% | ||
| Q4 24 | 8.7% | 0.0% | ||
| Q3 24 | 1.6% | 0.0% | ||
| Q2 24 | 2.8% | 0.0% | ||
| Q1 24 | 1.6% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | -4.09× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | -3.16× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | -5.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ISPO
| Residence And Hotel Travel | $25.9M | 47% |
| Subscription | $19.4M | 35% |
| Experiences And Bespoke Travel | $8.0M | 14% |
| Rewards And Other Revenue | $2.3M | 4% |
PBYI
Segment breakdown not available.
